Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops

QR Code

Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops

Eiichi UchioDepartment of Ophthalmology, Fukuoka University School of Medicine, Fukuoka, JapanAbstract: Olopatadine hydrochloride exerts a wide range of pharmacological actions such as histamine H1 receptor antagonist action, chemical mediator suppressive action, and eosinophil infiltration suppress...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Eiichi Uchio
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2008
Sujets:	Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/9f248f53c110442eba26dee9edf280ba
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model
par: Torkildsen G, et autres
Publié: (2015)

Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis
par: McLaurin E, et autres
Publié: (2017)

Azelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitis
par: Patricia B Williams, et autres
Publié: (2010)

Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies
par: Arthur B Epstein, et autres
Publié: (2009)

Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%
par: Jack V Greiner, et autres
Publié: (2011)

Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment
par: Mizoguchi T, et autres
Publié: (2017)

Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review
par: Makuloluwa AK, et autres
Publié: (2018)

Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
par: Jeremy B Wingard, et autres
Publié: (2011)

Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%
par: Bergmann MT, et autres
Publié: (2014)

Corneal sensitivity after topical bromfenac sodium eye-drop instillation
par: Yanai K, et autres
Publié: (2013)

Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis
par: Chigbu DI, et autres
Publié: (2015)

Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference
par: McCabe CF, et autres
Publié: (2012)

Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies
par: Meier E, et autres
Publié: (2017)

Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy
par: Gomes PJ, et autres
Publié: (2013)

Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections
par: Darlene Miller
Publié: (2008)

Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trial
par: Simmons PA, et autres
Publié: (2015)

Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model
par: Awara A, et autres
Publié: (2020)

Efficacy of retinol palmitate eye drops for dry eye in rabbits with lacrimal gland resection
par: Odaka A, et autres
Publié: (2012)

Virological and epidemiological analysis of coxsackievirus A24 variant epidemic of acute hemorrhagic conjunctivitis in Okinawa, Japan, in 2011
par: Harada K, et autres
Publié: (2015)

Proficiency of eye drop instillation in postoperative cataract patients in Ghana
par: Liu Y, et autres
Publié: (2013)

Lipid-containing osmoprotective eye drops in contact lens wearers
par: Aslan Bayhan S, et autres
Publié: (2014)

Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis
par: Daoud Al-Badriyeh, et autres
Publié: (2010)

The eye drop chart: a pilot study for improving administration of and compliance with topical treatments in glaucoma patients
par: McVeigh KA, et autres
Publié: (2015)

Systane&reg; lubricant eye drops in the management of ocular dryness
par: Benelli U
Publié: (2011)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
par: Inoue K, et autres
Publié: (2015)

Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis
par: Timothy L Comstock, et autres
Publié: (2010)

Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
par: Cervantes LJ, et autres
Publié: (2011)

Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials
par: Ciolino JB, et autres
Publié: (2015)

Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose
par: Cohen S, et autres
Publié: (2013)

Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects
par: Malhotra RP, et autres
Publié: (2019)

Fluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium
par: Ryou Watanabe, et autres
Publié: (2010)

Evaluation of the efficacy and safety of a new device for eye drops instillation in patients with glaucoma
par: Junqueira DM, et autres
Publié: (2015)

Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines
par: Masahiko Ayaki, et autres
Publié: (2010)

A randomized clinical evaluation of the safety of Systane&reg; Lubricant Eye Drops for the relief of dry eye symptoms following LASIK refractive surgery
par: Daniel Durrie, et autres
Publié: (2008)

Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections
par: Silverstein BE, et autres
Publié: (2012)

The effects of lubricant eye drops on visual function as measured by the Inter-blink interval Visual Acuity Decay test
par: Gail Torkildsen
Publié: (2009)

Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops
par: Rosin LM, et autres
Publié: (2013)

Antiadenoviral effects of N-chlorotaurine in vitro confirmed by quantitative polymerase chain reaction methods
par: Eiichi Uchio, et autres
Publié: (2010)

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile
par: Haas W, et autres
Publié: (2011)

Dexamethasone/Netilmicin Eye Drops and Eye Gel for the Treatment of Ocular Inflammation After Micro-Incisional Vitreoretinal Surgery
par: Rapisarda A, et autres
Publié: (2020)